Higher-dose lung radiation for early-stage lung cancer or a single lung tumor
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a higher-dose radiation treatment for lung cancer or a single tumor in the lung. It is designed for people who cannot have surgery or prefer not to, and whose tumor is near the chest wall making standard radiation difficult.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You are expected to live more than 6 months.
- You are able to care for yourself (up and about), even if you may need some help with daily tasks.
- You have either early-stage non-small cell lung cancer that has not spread, or a single cancer spot in the lung that has spread from another cancer.
- The tumor is located near your chest wall, making it hard to treat with standard radiation, but you are willing to receive a higher radiation dose to the tumor itself.
- Surgery is not an option for you, or you choose not to have surgery.
- You have not had radiation to the chest area in the past (excluding breast or chest wall radiation).
- You are not pregnant or breastfeeding, and you are willing to use birth control during treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This study compares two treatments—removing only part of the lung (sublobar resection) versus a focused radiation approach (stereotactic ablative radiotherapy)—for early-stage non-small cell lung cancer. It aims to see which option works better with fewer problems for the right patients.
This trial tests a precise, high-dose radiation treatment aimed at central lung tumors. It may help people who cannot have lung surgery and whose tumors can be safely targeted near sensitive organs.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.